• OPEN AN ACCOUNT
Indian Indices
Nifty
25,758.00 -81.65
(-0.32%)
Sensex
84,391.27 -275.01
( -0.32%)
Bank Nifty
58,960.40 -261.95
( -0.44%)
Nifty IT
37,789.90 -340.70
( -0.89%)
Global Indices
Nasdaq
48,074.52 493.22
(1.04%)
Dow Jones
6,906.36 44.85
(0.65%)
Hang Seng
50,565.27 -89.83
(-0.18%)
Nikkei 225
9,661.39 19.38
(0.20%)
Forex
USD-INR
90.09 0.19
(0.21%)
EUR-INR
104.90 0.24
(0.23%)
GBP-INR
120.04 0.25
(0.21%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5600262
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.14
120289.25
EPS(TTM)
Face Value()
Div & Yield %
64.35
2
1.07
 

Piramal Enterprises CFO Upma Goel resigns
Sep 20,2025
In a regulatory filing, the company informed that Goel’s resignation has been accepted by the board, and her last working day will be at the close of business hours on 30 September 2025.

Piramal Enterprises (PEL) is a leading diversified NBFC in India, with prominent presence across retail and wholesale lending, alternatives and insurance.

The company’s consolidated net profit surged 52.3% to Rs 276.37 crore on 23.8% rise in net sales to Rs 2,560.61 crore in Q1 FY26 over Q1 FY25.

The counter dropped 4.81% to end at Rs 1,121.80 on the BSE on Friday, 19 September 2025.